Your browser doesn't support javascript.
loading
Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis.
Orset, Cyrille; Haelewyn, Benoit; Allan, Stuart M; Ansar, Saema; Campos, Francesco; Cho, Tae Hee; Durand, Anne; El Amki, Mohamad; Fatar, Marc; Garcia-Yébenes, Isaac; Gauberti, Maxime; Grudzenski, Saskia; Lizasoain, Ignacio; Lo, Eng; Macrez, Richard; Margaill, Isabelle; Maysami, Samaneh; Meairs, Stephen; Nighoghossian, Norbert; Orbe, Josune; Paramo, Jose Antonio; Parienti, Jean-Jacques; Rothwell, Nancy J; Rubio, Marina; Waeber, Christian; Young, Alan R; Touzé, Emmanuel; Vivien, Denis.
Affiliation
  • Orset C; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Haelewyn B; Experimental Stroke Research Platform, CURB, University Caen Normandie, Caen, France.
  • Allan SM; Experimental Stroke Research Platform, CURB, University Caen Normandie, Caen, France.
  • Ansar S; University of Manchester, Faculty of Medical and Health Sciences, Manchester, United Kingdom.
  • Campos F; Neurologische Universitätsklinik, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
  • Cho TH; Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Durand A; Dept of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
  • El Amki M; Department of Neurology, Neurovascular Area, Clinical Neurosciences Research Laboratory, Hospital Clínico Universitario, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Fatar M; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Garcia-Yébenes I; Dept of Stroke Medicine and Department of Neuroradiology; Université Lyon 1; CREATIS, CNRS UMR 5220-INSERM U1044 ; Hospices Civils de Lyon ; Lyon, France.
  • Gauberti M; Dept of Stroke Medicine and Department of Neuroradiology; Université Lyon 1; CREATIS, CNRS UMR 5220-INSERM U1044 ; Hospices Civils de Lyon ; Lyon, France.
  • Grudzenski S; EA4475 Pharmacologie de la Circulation Cérébrale, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France.
  • Lizasoain I; Department of Neurology, Universitätsmedizin Mannheim, University of Heidelberg, Germany.
  • Lo E; Unidad de Investigación Neurovascular, Departamento Farmacología, Facultad de Medicina, Universidad Complutense and Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
  • Macrez R; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Margaill I; Department of Neurology, Universitätsmedizin Mannheim, University of Heidelberg, Germany.
  • Maysami S; Unidad de Investigación Neurovascular, Departamento Farmacología, Facultad de Medicina, Universidad Complutense and Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
  • Meairs S; Departments of Radiology, and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, USA.
  • Nighoghossian N; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Orbe J; EA4475 Pharmacologie de la Circulation Cérébrale, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France.
  • Paramo JA; University of Manchester, Faculty of Medical and Health Sciences, Manchester, United Kingdom.
  • Parienti JJ; Neurologische Universitätsklinik, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
  • Rothwell NJ; Dept of Stroke Medicine and Department of Neuroradiology; Université Lyon 1; CREATIS, CNRS UMR 5220-INSERM U1044 ; Hospices Civils de Lyon ; Lyon, France.
  • Rubio M; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Waeber C; Inserm UMR-S U919, University Caen Normandie, GIP Cyceron, Caen, France.
  • Young AR; Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA-University of Navarra, Pamplona, Spain.
  • Touzé E; Departments of Biostatistics and Clinical Research, Centre Hospitalier Universitaire (CHU), Caen ; EA4655 Risques Microbiens, Université de Caen Normandie, Caen, France.
  • Vivien D; University of Manchester, Faculty of Medical and Health Sciences, Manchester, United Kingdom.
Stroke ; 47(5): 1312-1318, 2016 05.
Article in En | MEDLINE | ID: mdl-27032444

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Risk_factors_studies / Systematic_reviews Limits: Animals Language: En Journal: Stroke Year: 2016 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Risk_factors_studies / Systematic_reviews Limits: Animals Language: En Journal: Stroke Year: 2016 Type: Article Affiliation country: France